Picture of BrightPath Biotherapeutics Co logo

4594 BrightPath Biotherapeutics Co News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Table: Green Peptide -6-MTH parent results

Nov 11 (Reuters)-  
             Green Peptide Co., Ltd.  
             PARENT-ONLY FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 6 months ended      6 months ended        Year to   
                Sep 30, 2016        Sep 30, 2015      Mar 31, 2017   
                   LATEST             YEAR-AGO           LATEST      
                   RESULTS             RESULTS          FORECAST     
  Sales            317 mln             415 mln           406 mln     
                 (-23.8 pct)                           (-50.5 pct)   
  Operating     loss 468 mln        loss 606 mln        loss 1.31    
  Recurring     loss 472 mln        loss 593 mln        loss 1.31    
  Net           loss 476 mln        loss 594 mln        loss 1.31    
  EPS          loss 14.58 yen      loss 23.50 yen    loss 41.14 yen  
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
   
  NOTE - Green Peptide Co., Ltd..  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on BrightPath Biotherapeutics Co

See all news